US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Holdings

3,192.87

-87.7664-2.68%

Number of Gainers:19

Number of Losers:52

Number of Flat:2

PE:- -

High:3,306.66

Open:3,280.06

Low:3,189.38

Close:3,280.46

Loading ...

Top Midday Gainers

MT Newswires Live

Akero Therapeutics Advances Efruxifermin Study for NASH Treatment

Amgen’s New Study on AMG 410: A Potential Game-Changer in Cancer Treatment

XPeng, Li Auto, NIO, or BYD: Which Chinese EV Maker Had the Strongest July?

Apple Posted 'Solid' Results on Beats Across the Board, China Rebound, Wedbush Says

MT Newswires Live

BRIEF-Allogene Therapeutics Selects Standard FC Regimen For Alpha3 Study - SEC Filing

FMR LLC Reports Disposal of Common Shares of Beam Therapeutics Inc

I-Mab Prices $65 Million Offering of American Depositary Shares

MT Newswires Live

Allogene Therapeutics Inc: None of Co's Trials Open to Enrollment or Pipeline Programs Include Allo-647

THOMSON REUTERS

Allogene Therapeutics Inc - Fc Plus Allo-647 Arm Closed Due to Adverse Event - SEC Filing

THOMSON REUTERS

Allogene Therapeutics: Will Advance Next-Generation Allocar T Product Candidates Using Proprietary Dagger Platform Technology

THOMSON REUTERS

Market Chatter: Starbucks Shortlists Potential Investors in China Business

MT Newswires Live

Allogene Therapeutics Announces Launch of ALPHA3 Study Using Standard Fludarabine and Cyclophosphamide for Large B-Cell Lymphoma

Everest Medicines Ltd. Expands Stake with $30.9 Million Investment in U.S.-Based Biotech Firm I-Mab

Argenx price target raised to $880 from $829 at BofA

I-Mab prices 33.3M ADSs at $1.95 in underwritten offering

Taiwan Semi put buyer realizes 4% same-day gains

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

Is Alibaba's Valuation Way Too Cheap -- or a Justified Risk?

XPeng Reports Higher Deliveries for July

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4505/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4505","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4505\",,,,,undefined,":{"symbol":"BK4505","market":"US","secType":"PLATE","nameCN":"Hillhouse Capital Holdings","latestPrice":3192.6938,"timestamp":1754072144931,"preClose":3280.4602,"halted":0,"volume":318870843,"delay":0,"changeRate":-0.026754,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-87.766357,"latestTime":"08-01 14:15:45 EDT","open":3280.0647,"high":3306.6597,"low":3189.3774,"amount":24138758750.537388,"amplitude":0.035752,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1754078400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.546119,"peRate":27.252735,"turnoverRate":0.007933,"increases":19,"decrements":52,"flats":2,"marketCap":5885136661043,"floatMarketCap":5506020340199.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4505\",,,,,undefined,":{"symbol":"BK4505","high":3306.6597,"amplitude":0.035752,"preClose":3280.4602,"low":3189.3774,"pbRate":"8.546119","latestPrice":3192.8657,"volume":318891831,"delay":0,"open":3280.0647,"prevYearClose":3417.1636,"prevWeekClose":3365.1438,"prevMonthClose":3280.4602,"prevQuarterClose":3213.6726,"fiveDayClose":3365.1438,"twentyDayClose":3302.439,"sixtyDayClose":2985.469,"secType":"PLATE","market":"US","turnoverRate":0.007934,"peRate":27.252735,"marketCap":5885126524467,"floatMarketCap":5506009200615.5,"timestamp":1754072147981,"nameCN":"Hillhouse Capital Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4505\",,,,undefined,":{"bkCode":"BK4505","up":19,"down":52,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4505\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556848563","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2556848563","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556848563?lang=en_us&edition=fundamental","pubTime":"2025-08-02 01:29","pubTimestamp":1754069361,"startTime":"0","endTime":"0","summary":"Performant Healthcare  agreed to be acquired by Machinify, a health-care intelligence company backed by New Mountain Capital, for $670 million.Shares of Performant more than doubled as intraday volume topped 14.4 million shares versus the daily average of almost 192,000.Tenon Medical  acquired sacroiliac joint-focused assets from Tampa, Florida-based startup SiVantage.Shares of Tenon rose 54% as volume topped 220.7 million versus the daily average of almost 212,000.I-MAB  priced an underwritten offering of 33.3 million American depositary shares, representing 76.7 million ordinary shares, at $1.95 each for total proceeds of $65 million.The stock jumped 25% as volume topped 41 million versus the daily average of about 587,000.Price: 7.62, Change: +4.07, Percent Change: +114.65","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","BK4535","BK4505","BK4139","BK4082","BK4196","PHLT","TNON","IMAB"],"gpt_icon":0},{"id":"2556810133","title":"Akero Therapeutics Advances Efruxifermin Study for NASH Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2556810133","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556810133?lang=en_us&edition=fundamental","pubTime":"2025-08-02 00:33","pubTimestamp":1754066030,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Akero Therapeutics is conducting a Phase 3 study titled ‘A Study ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-efruxifermin-study-for-nash-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akero-therapeutics-advances-efruxifermin-study-for-nash-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4585","BK4588","AKRO"],"gpt_icon":0},{"id":"2556810312","title":"Amgen’s New Study on AMG 410: A Potential Game-Changer in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2556810312","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556810312?lang=en_us&edition=fundamental","pubTime":"2025-08-02 00:19","pubTimestamp":1754065189,"startTime":"0","endTime":"0","summary":"Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. has announced a new clinical study titled A Phase 1/1b Study Ev...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-new-study-on-amg-410-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-new-study-on-amg-410-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU2242652126.USD","BK4566","BK4585","LU2468319806.SGD","IE0009355771.USD","LU1057294990.SGD","LU0058720904.USD","LU1983299246.USD","AMG","BK4505","IE00B2B36J28.USD","BK4139","BK4534","LU0320765992.SGD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4588","IE0002141913.USD","LU0889565916.HKD","LU2089984988.USD","LU1571399168.USD","LU2242646821.SGD","LU0868494617.USD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","AMGN","BK4581","BK4533","IE00BJT1NW94.SGD","BK4135","LU1023059063.AUD","LU0289739699.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2556781739","title":"XPeng, Li Auto, NIO, or BYD: Which Chinese EV Maker Had the Strongest July?","url":"https://stock-news.laohu8.com/highlight/detail?id=2556781739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556781739?lang=en_us&edition=fundamental","pubTime":"2025-08-01 23:13","pubTimestamp":1754061183,"startTime":"0","endTime":"0","summary":"Chinese electric vehicle (EV) makers posted a mixed bag of delivery results for July, with XPeng ($XPEV) reporting record sales, while other major ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/xpeng-li-auto-nio-or-byd-which-chinese-ev-maker-had-the-strongest-july?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/xpeng-li-auto-nio-or-byd-which-chinese-ev-maker-had-the-strongest-july?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4099","BK4504","BK4555","BK4532","BK4585","BK4574","EVS.SI","LI","BK4548","BK4503","LU0052750758.USD","XPEV","BK4509","LU0708995583.HKD","NIO.SI","LU0320764599.SGD","BK4581","BK4551","BK4534","BK4563","NIO","BK4505","BK4588","09866","BK4526","BK4531"],"gpt_icon":0},{"id":"2556681730","title":"Apple Posted 'Solid' Results on Beats Across the Board, China Rebound, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2556681730","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556681730?lang=en_us&edition=fundamental","pubTime":"2025-08-01 22:31","pubTimestamp":1754058672,"startTime":"0","endTime":"0","summary":"Apple  delivered \"solid\" fiscal Q3 results on beats across the board, fuelled by double-digit growth in iPhone, Mac and Services, Wedbush Securities said in a note Friday.The firm also noted the 4% year-over-year growth in the Greater China region because of strength from iPhone upgraders and robust demand for Mac products.At the same time, Wedbush said Apple's artificial intelligence investments are \"not moving the needle.\"\"It's clear to us the innovations around AI are not going to come from Apple Park,\" the firm said. \"Apple needs to acquire Perplexity to truly catalyze its AI strategy among other options.\"Wedbush maintained the company's outperform rating and $270 price target.Price: 206.37, Change: -1.20, Percent Change: -0.58","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0061474960.USD","LU2133065610.SGD","LU1244550221.USD","LU1551013425.SGD","AAPL","LU1066051498.USD","LU0011850046.USD","BK4566","BK4585","LU1917777945.USD","LU0528227936.USD","LU1280957306.USD","LU1506573853.SGD","LU2237443382.USD","LU1316542783.SGD","LU0082616367.USD","LU0820561818.USD","LU0109391861.USD","BK4571","BK4505","LU1066051811.HKD","IE0004091025.USD","BK4553","LU0314104364.USD","LU0957808578.USD","LU1914381329.SGD","LU1934455277.USD","LU2417539215.USD","LU2860962120.EUR","IE00BN29S564.USD","LU1235294995.USD","LU1868836757.USD","LU0985320562.USD","LU1145028129.USD","LU0109392836.USD","LU2237438978.USD","LU2471134879.HKD","LU0096362180.USD","LU1232071149.USD","IE00BK4W5L77.USD","BK4573","SG9999002224.SGD","LU1989772840.SGD","MACW.SI","IE00B1XK9C88.USD","LU1935042488.USD","IE00BK4W5M84.HKD","LU0157215616.USD","LU1582987597.SGD","LU1720051108.HKD"],"gpt_icon":1},{"id":"2556081151","title":"BRIEF-Allogene Therapeutics Selects Standard FC Regimen For Alpha3 Study - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556081151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556081151?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:54","pubTimestamp":1754056490,"startTime":"0","endTime":"0","summary":"BRIEF-Allogene Therapeutics Selects Standard FC Regimen For Alpha3 Study - SEC FilingAug 1  - Allogene Therapeutics Inc ALLO.O:ALLOGENE THERAPEUTICS INC - SELECTS STANDARD FC REGIMEN FOR ALPHA3 STUDY - SEC FILINGALLOGENE THERAPEUTICS INC - FC PLUS ALLO-647 ARM CLOSED DUE TO ADVERSE EVENT - SEC FILINGALLOGENE THERAPEUTICS INC: NONE OF CO'S TRIALS OPEN TO ENROLLMENT OR PIPELINE PROGRAMS INCLUDE ALLO-647ALLOGENE THERAPEUTICS: WILL ADVANCE NEXT-GENERATION ALLOCAR T PRODUCT CANDIDATES USING PROPRIETARY DAGGER PLATFORM TECHNOLOGYALLOGENE THERAPEUTICS: GRADE 5 ADVERSE EVENT IN FC PLUS ALLO-647 ARM ATTRIBUTED TO USE OF ALLO-647Source text: [ID:n0001193125-25-171091]Further company coverage: ALLO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2556819111","title":"FMR LLC Reports Disposal of Common Shares of Beam Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819111","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556819111?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:36","pubTimestamp":1754055416,"startTime":"0","endTime":"0","summary":"FMR LLC, a beneficial owner, reported a disposal of common shares of Beam Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDLbRwY88:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4611","BK4535","BK4505","BK4139","BK4585","BK4588","BK4556"],"gpt_icon":0},{"id":"2556141388","title":"I-Mab Prices $65 Million Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2556141388","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556141388?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:28","pubTimestamp":1754054935,"startTime":"0","endTime":"0","summary":"I-MAB  said Friday that it has priced an underwritten offering of 33.3 million American depositary shares, representing 76.7 million ordinary shares, at $1.95 each for total proceeds of $65 million.I-Mab said that it expects to close the offering around Tuesday, with the proceeds going toward clinical development of drug candidates and general corporate purposes.Shares of I-Mab were up more than 18% in recent Friday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","BK4535","BK4505","BK4139","IMAB","BK4107","BK4117","AFG"],"gpt_icon":0},{"id":"2556819543","title":"Allogene Therapeutics Inc: None of Co's Trials Open to Enrollment or Pipeline Programs Include Allo-647","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556819543?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:27","pubTimestamp":1754054821,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2556599819","title":"Allogene Therapeutics Inc - Fc Plus Allo-647 Arm Closed Due to Adverse Event - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556599819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556599819?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:27","pubTimestamp":1754054821,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2556195488","title":"Allogene Therapeutics: Will Advance Next-Generation Allocar T Product Candidates Using Proprietary Dagger Platform Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2556195488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556195488?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:27","pubTimestamp":1754054821,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2556164468","title":"Market Chatter: Starbucks Shortlists Potential Investors in China Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2556164468","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556164468?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:57","pubTimestamp":1754053058,"startTime":"0","endTime":"0","summary":"Starbucks  has shortlisted about a dozen potential investors, including private equity firms and technology companies, for the next round of an investment process for its China business, Bloomberg reported Friday, citing people familiar with the matter.Among those invited to participate are private equity firms Boyu Capital, Carlyle Group , EQT AB, FountainVest Partners, KKR , Hillhouse Investment, and Primavera Capital, along with tech giants JD.com  and Tencent, the report said.These shortlisted parties will be granted access to Starbucks' China financials, Bloomberg said.Starbucks, KKR and Carlyle declined to comment to MT Newswires, while JD.com didn't immediately reply to a request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0106831901.USD","LU0130102774.USD","BK4135","LU0823411888.USD","KKR","BK4579","LU0648001328.SGD","BK4551","CG","BK4220","BK4558","BK4524","IE00B64PRP62.GBP","BK4211","LU1935042215.USD","SG9999002463.SGD","BK4588","BK4509","BK4209","LU1188198961.HKD","LU0307460666.USD","LU1688375341.USD","IE00BGHQF748.EUR","LU0326950275.SGD","BK4505","BK4531","LU1935042991.SGD","IE0008368742.USD","BK4535","HK0000306685.HKD","BK4610","LU0980610538.SGD","BK4122","HK0000306701.USD","BK4504","BK4614","LU1880383366.USD","LU1791807156.HKD","ISBC","LU0244354667.USD","LU0588546209.SGD","HK0000320264.USD","LU1935042488.USD","LU1935043536.SGD","IE00B3QW5Z07.USD","BK4526","SBUX","LU1935043023.USD"],"gpt_icon":1},{"id":"2556815290","title":"Allogene Therapeutics Announces Launch of ALPHA3 Study Using Standard Fludarabine and Cyclophosphamide for Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2556815290","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556815290?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:30","pubTimestamp":1754051428,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Announces Launch of ALPHA3 Study Using Standard Fludarabine and Cyclophosphamide for Large B-Cell Lymphoma. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL2mc4l8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4505","LU2210150020.SGD","LU0314104364.USD","LU2095319765.USD","BK4139","NDAQ","BK4585","ALLO","BK4112","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2556668815","title":"Everest Medicines Ltd. Expands Stake with $30.9 Million Investment in U.S.-Based Biotech Firm I-Mab","url":"https://stock-news.laohu8.com/highlight/detail?id=2556668815","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556668815?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:17","pubTimestamp":1754050665,"startTime":"0","endTime":"0","summary":"Everest Medicines Ltd., a biopharmaceutical company, has expanded its portfolio by subscribing to 15,846,154 American depositary shares of I-Mab, a U.S.-based biotech company specializing in precision immuno-oncology agents. The transaction, valued at approximately US$30.9 million, enhances Everest Medicines' stake in I-Mab to 16.1% of its total issued share capital. This strategic move aligns with Everest Medicines' commitment to advancing novel therapies addressing critical unmet medical needs. The company continues to build its portfolio of first-in-class or best-in-class products, further solidifying its presence in the global biotech industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the orig","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL9T24Wl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4535","BK4505","BK1574","BK4139","BK1161","01952","IMAB","BK1583"],"gpt_icon":0},{"id":"2556815104","title":"Argenx price target raised to $880 from $829 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2556815104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556815104?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:11","pubTimestamp":1754050315,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Argenx (ARGX) to $880 from $829 and keeps a Buy rating on the shares. Gross-to-net concerns are “put to rest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-880-from-829-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-880-from-829-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4139","BK4505","ARGX","BK4585","LU0109394709.USD","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2556815106","title":"I-Mab prices 33.3M ADSs at $1.95 in underwritten offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2556815106","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556815106?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:11","pubTimestamp":1754050300,"startTime":"0","endTime":"0","summary":"I-Mab (IMAB) announced the pricing of an underwritten offering in the United States of 33,333,334 American Depositary Shares representing 76,666,66...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/i-mab-prices-33-3m-adss-at-1-95-in-underwritten-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/i-mab-prices-33-3m-adss-at-1-95-in-underwritten-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4526","BK4535","BK4505","BK4139","IMAB"],"gpt_icon":0},{"id":"2556707813","title":"Taiwan Semi put buyer realizes 4% same-day gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2556707813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556707813?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:00","pubTimestamp":1754049654,"startTime":"0","endTime":"0","summary":"Notable profits for the buyer who lifted the $8.10 offer for 9,999 Taiwan Semi (TSM) 9/5 weekly 240 puts yesterday at 11:15ET when underlying share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/taiwan-semi-put-buyer-realizes-4-same-day-gains-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/taiwan-semi-put-buyer-realizes-4-same-day-gains-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1282649067.USD","LU2023251221.USD","LU2471134523.USD","BK4527","LU2250418816.HKD","LU1989772923.USD","LU0823421333.USD","BK4550","TSM","SG9999004220.SGD","LU2023250504.SGD","IE00BZ199S13.USD","IE00BQXX3C00.GBP","IE00BD6J9T35.USD","LU2471134796.USD","LU2237443382.USD","BK4505","LU2211814178.USD","BK4548","LU0353189763.USD","LU0823421416.USD","LU0094547139.USD","LU2860962120.EUR","LU0719512351.SGD","BK4612","LU0198837287.USD","LU0823414478.USD","LU0316494557.USD","LU0348723411.USD","LU0384037296.USD","LU2357125470.USD","LU2028103732.USD","LU2491050071.SGD","LU0264606111.USD","IE0004086264.USD","03145","LU2458330243.SGD","LU2125154778.USD","BK4543","BK4141","LU2237443549.SGD","LU2360032135.SGD","LU0878005551.USD","SG9999000418.SGD","LU1989764664.SGD","LU0158827781.USD","BK4591","BK4512","IE00BHPRN162.USD","LU0238689110.USD"],"gpt_icon":0},{"id":"2556815377","title":"I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2556815377","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556815377?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:00","pubTimestamp":1754049600,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Aug.  01, 2025  (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the tre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/01/3125737/0/en/I-Mab-Announces-Pricing-of-65-Million-Underwritten-Offering-of-American-Depositary-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4195","BK4505","BK4211","PFS","BK4107","BK4117","IMAB","AFG","BK4535","BK4526"],"gpt_icon":0},{"id":"2556158118","title":"Is Alibaba's Valuation Way Too Cheap -- or a Justified Risk?","url":"https://stock-news.laohu8.com/highlight/detail?id=2556158118","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556158118?lang=en_us&edition=fundamental","pubTime":"2025-08-01 19:45","pubTimestamp":1754048700,"startTime":"0","endTime":"0","summary":"China's top e-commerce and cloud company is still trading at historically low valuations.","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F826155%2Fumbrella-shanghai.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F826155%2Fumbrella-shanghai.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/08/01/is-alibabas-valuation-way-too-cheap-or-justified/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0501845795.SGD","LU1282648689.USD","BK4588","BK4534","BK4543","BK4505","09988","BK4538","LU1051768304.USD","LU1048588211.SGD","LU1048596156.SGD","ALBmain","LU0348816934.USD","LU0072462343.USD","BK4585","BK4587","LU0310800965.SGD","LU0328353924.USD","LU1046421795.USD","LU1235294995.USD","LU0880133367.SGD","BK4535","LU1105468828.SGD","BK4558","BABA","LU0651947912.USD","LU0348814723.USD","LU0052756011.USD","LU2226246903.HKD","BK4527","BK4565","BK4526","LU0067412154.USD","BK4548","BK4159","LU1515016050.SGD","LU1267930227.SGD","BK4502","IE00BFMHRM44.USD","LU0072913022.USD","LU1046422090.SGD","LU1008478684.HKD","LU0251143458.SGD","LU1688375341.USD","CAGR","LU1769817179.HKD","BK4533","BK4220","LU0918141705.HKD"],"gpt_icon":1},{"id":"2556818426","title":"XPeng Reports Higher Deliveries for July","url":"https://stock-news.laohu8.com/highlight/detail?id=2556818426","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556818426?lang=en_us&edition=fundamental","pubTime":"2025-08-01 19:37","pubTimestamp":1754048241,"startTime":"0","endTime":"0","summary":"XPeng (XPEV) reported late Thursday that it delivered 36,717 smart electric vehicles in July, up 229% year-over-year.In the first seven months of this year, the company's deliveries jumped 270% from a year earlier to 233,906 units.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","BK4551","BK4505","EVS.SI","BK4099","BK4555","XPEV"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":1,"totalSize":413,"code":"91000000","status":"200"}]}}